Rat Model Market Size by Model Type, Service, Technology, Therapeutic Area, Care Product, End-User, Region, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2032
8.06%
CAGR (2026-2032)
788.43 USD Mn.
Market Size
322
Report Pages
160
Market Tables
Overview
The Rat Model Market size was valued at USD 788.43 Million in 2025 and the total Rat Model revenue is expected to grow at a CAGR of 8.06% from 2025 to 2032, reaching nearly USD 1356.49 Million by 2032.
Rat model is used for research in biomedical science and psychology. Rats and humans have numerous similarities like physiology, similar body organs, similar genetic structure to humans and frequently suffer from the same diseases.
An increase in usage of the rat model in biomedical research for understanding the current health issues is boosting the growth in the market. Continuous research and development activities, research funding and grants and introduction of personalized medicine are the prime factors behind the growth of the rat model market. On the other hand, Fimmoral practices of animal model systems in research and changing rules and regulations on animal testing are limiting the growth of the rat model market.
To know about the Research Methodology :- Request Free Sample Report
Inbred rats are segment is expected to contribute significant share in the global rat model market. The maximum share in the market is attributed to the rise in usage of the inbred rat models to study various complex disorders like cardiovascular disorders, cancer research, and neurodegenerative disorders.
CRISPR technology is expected to hold the dominant position in the global rat model market. The demand for CRISPR technology among researchers is increasing because of some factors like potential reduction in animal usage, cost-effectiveness, and time savings. CRISPR technology is also expected to cover the way for any number of new genetic rat models, which are mainly used for neuroscience research and new genetic models.
The toxicology settings segment is expected to contribute maximum share in the market. Toxicology is the study of the adversative effects of chemical, physical, or biological agents on people, animals, and the environment. Rats are mostly used in the toxicity and safety assessment studies of a drug constituent. Toxicology testing in animals is necessary to demonstrate the new drugs are safe before their utilization in humans.
Region-wise, The North America region is estimated to hold the dominant position in the global rat model market. The presence of biotech and pharmaceutical companies, along with recognized research and development institutes are expected to drive the market growth in the region. An Increase in demand for rats in pre-clinical animal trail studies by CROs, pharmaceutical companies, and life science research institutions and availability of rat models are some of the factors behind the market growth in North America.
The objective of the report is to present a comprehensive analysis of Global Rat Model Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market are presented in the report.
External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Rat Model Market dynamics, structure by analysing the market segments and project the Global Rat Model Market size. Clear representation of competitive analysis of key players by Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Rat Model Market make the report investor’s guide.
The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.
Rat Model Market Scope: Inquire before buying
| Global Rat Model Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2032 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | USD 788.43 Mn. |
| Forecast Period 2026 to 2032 CAGR: | 8.06% | Market Size in 2032: | USD 1356.49 Mn. |
| Segments Covered: | by Model Type | Outbred Rats Inbred Rats Knockout/Genetically Modified Rats Hybrid/Congenic Rats Conditioned/Surgically Modified Rats Immunodeficient Rats |
|
| by Service | Breeding Cryopreservation Quarantine Rederivation Model-in-licensing Genetic Testing Other Services |
||
| by Technology | CRISPR Microinjection Embryonic Stem Cell Nuclear Transfer |
||
| by Therapeutic Area | Toxicology Oncology Immunology and Inflammation Neurology Diabetes Other Therapeutic Areas |
||
| by Care Product | Cages Feed Bedding Other Care Products |
||
| by End-User | Pharmaceutical & Biotechnology Companies Academic & Research Institutes Contract Research Organizations |
||
Rat Model Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Rat Model Market, Key Players
1.Genoway S.A.
2.Biomere
3.Transposagen Biopharmaceuticals, Inc.
4.Horizon Discovery Group PLC
5.Transviragen, Inc.
6.Charles River Laboratories International, Inc.
7.Taconic Biosciences, Inc.
8.Envigo
9.Laboratory Corporation of America Holdings
10.Janvier Labs
11.Harlan Laboratories, Inc.
12.SAGE Labs
13.Applied StemCell
14.Regenera Pharma
15.Active C60
Frequently Asked Questions:
1. Which region has the largest share in Global Rat Model Market?
Ans: North America region held the highest share in 2025.
2. What is the growth rate of Global Rat Model Market?
Ans: The Global market is growing at a CAGR of 8.06% during forecasting period 2026-2032.
3. What is scope of the Global Rat Model market report?
Ans: GlobalMarket report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Rat Model market?
Ans: The important key players in the Global Market are – Genoway S.A., Biomere, Transposagen Biopharmaceuticals, Inc., Horizon Discovery Group PLC, Transviragen, Inc., Charles River Laboratories International, Inc., Taconic Biosciences, Inc., Envigo, Laboratory Corporation of America Holdings, Janvier Labs, Harlan Laboratories, Inc., SAGE Labs, Applied StemCell, Regenera Pharma, and Active C60.
5. What is the study period of this market?
Ans: The Global Market is studied from 2025 to 2032.
Table of Contents
Global Rat Model Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Rat Model Market Size, by Market Value (US$ Mn)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
5. Supply Side and Demand Side Indicators
6. Global Rat Model Market Analysis and Forecast
6.1. Global Rat Model Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America
7. Global Rat Model Market Analysis and Forecast, by Model Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Rat Model Market Value Share Analysis, by Model Type
7.4. Global Rat Model Market Size (US$ Mn) Forecast, by Model Type
7.5. Global Rat Model Market Analysis, by Model Type
7.6. Global Rat Model Market Attractiveness Analysis, by Model Type
8. Global Rat Model Market Analysis and Forecast, by Service
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Rat Model Market Value Share Analysis, by Service
8.4. Global Rat Model Market Size (US$ Mn) Forecast, by Service
8.5. Global Rat Model Market Analysis, by Service
8.6. Global Rat Model Market Attractiveness Analysis, by Service
9. Global Rat Model Market Analysis and Forecast, by Therapeutic Area
9.1. Introduction and Definition
9.2. Key Findings
9.3. Global Rat Model Market Value Share Analysis, by Therapeutic Area
9.4. Global Rat Model Market Size (US$ Mn) Forecast, by Therapeutic Area
9.5. Global Rat Model Market Analysis, by Therapeutic Area
9.6. Global Rat Model Market Attractiveness Analysis, by Therapeutic Area
10. Global Rat Model Market Analysis and Forecast, by Care Product
10.1. Introduction and Definition
10.2. Key Findings
10.3. Global Rat Model Market Value Share Analysis, by Care Product
10.4. Global Rat Model Market Size (US$ Mn) Forecast, by Care Product
10.5. Global Rat Model Market Analysis, by Care Product
10.6. Global Rat Model Market Attractiveness Analysis, by Care Product
11. Global Rat Model Market Analysis and Forecast, by End-user
11.1. Introduction and Definition
11.2. Key Findings
11.3. Global Rat Model Market Value Share Analysis, by End-user
11.4. Global Rat Model Market Size (US$ Mn) Forecast, by End-user
11.5. Global Rat Model Market Analysis, by End-user
11.6. Global Rat Model Market Attractiveness Analysis, by End-user
12. Global Rat Model Market Analysis and Forecast, by Technology
12.1. Introduction and Definition
12.2. Key Findings
12.3. Global Rat Model Market Value Share Analysis, by Technology
12.4. Global Rat Model Market Size (US$ Mn) Forecast, by Technology
12.5. Global Rat Model Market Analysis, by Technology
12.6. Global Rat Model Market Attractiveness Analysis, by Technology
13. Global Rat Model Market Analysis, by Region
13.1. Global Rat Model Market Value Share Analysis, by Region
13.2. Global Rat Model Market Size (US$ Mn) Forecast, by Region
13.3. Global Rat Model Market Attractiveness Analysis, by Region
14. North America Rat Model Market Analysis
14.1. Key Findings
14.2. North America Rat Model Market Overview
14.3. North America Rat Model Market Value Share Analysis, by Model Type
14.4. North America Rat Model Market Forecast, by Model Type
14.4.1. Outbred Rats
14.4.2. Inbred Rats
14.4.3. Knockout/Genetically Modified Rats
14.4.4. Hybrid/Congenic Rats
14.4.5. Conditioned/Surgically Modified Rats
14.4.6. Immunodeficient Rats
14.5. North America Rat Model Market Value Share Analysis, by Service
14.6. North America Rat Model Market Forecast, by Service
14.6.1. Breeding
14.6.2. Cryopreservation
14.6.3. Quarantine
14.6.4. Rederivation
14.6.5. Model-in-licensing
14.6.6. Genetic Testing
14.6.7. Other Services
14.7. North America Rat Model Market Value Share Analysis, by Therapeutic Area
14.8. North America Rat Model Market Forecast, by Therapeutic Area
14.8.1. Toxicology
14.8.2. Oncology
14.8.3. Immunology and Inflammation
14.8.4. Neurology
14.8.5. Diabetes
14.8.6. Other Therapeutic Areas
14.9. North America Rat Model Market Value Share Analysis, by Care Product
14.10. North America Rat Model Market Forecast, by Care Product
14.10.1. Cages
14.10.2. Feed
14.10.3. Bedding
14.10.4. Others
14.11. North America Rat Model Market Value Share Analysis, by End-user
14.12. North America Rat Model Market Forecast, by End-user
14.12.1. Pharmaceutical & Biotechnology Companies
14.12.2. Academic & Research Institutes
14.12.3. Contract Research Organizations (CROs)
14.13. North America Rat Model Market Value Share Analysis, by Technology
14.14. North America Rat Model Market Forecast, by Technology
14.14.1. CRISPR
14.14.2. Microinjection
14.14.3. Embryonic Stem Cell
14.14.4. Nuclear Transfer
14.15. North America Rat Model Market Value Share Analysis, by Country
14.16. North America Rat Model Market Forecast, by Country
14.16.1. U.S.
14.16.2. Canada
14.17. North America Rat Model Market Analysis, by Country
14.18. U.S. Rat Model Market Forecast, by Model Type
14.18.1. Outbred Rats
14.18.2. Inbred Rats
14.18.3. Knockout/Genetically Modified Rats
14.18.4. Hybrid/Congenic Rats
14.18.5. Conditioned/Surgically Modified Rats
14.18.6. Immunodeficient Rats
14.19. U.S. Rat Model Market Forecast, by Service
14.19.1. Breeding
14.19.2. Cryopreservation
14.19.3. Quarantine
14.19.4. Rederivation
14.19.5. Model-in-licensing
14.19.6. Genetic Testing
14.19.7. Other Services
14.20. U.S. Rat Model Market Forecast, by Therapeutic Area
14.20.1. Toxicology
14.20.2. Oncology
14.20.3. Immunology and Inflammation
14.20.4. Neurology
14.20.5. Diabetes
14.20.6. Other Therapeutic Areas
14.21. U.S. Rat Model Market Forecast, by Care Product
14.21.1. Cages
14.21.2. Feed
14.21.3. Bedding
14.21.4. Others
14.22. U.S. Rat Model Market Forecast, by End-user
14.22.1. Pharmaceutical & Biotechnology Companies
14.22.2. Academic & Research Institutes
14.22.3. Contract Research Organizations (CROs)
14.23. U.S. Rat Model Market Forecast, by Technology
14.23.1. CRISPR
14.23.2. Microinjection
14.23.3. Embryonic Stem Cell
14.23.4. Nuclear Transfer
14.24. Canada Rat Model Market Forecast, by Model Type
14.24.1. Outbred Rats
14.24.2. Inbred Rats
14.24.3. Knockout/Genetically Modified Rats
14.24.4. Hybrid/Congenic Rats
14.24.5. Conditioned/Surgically Modified Rats
14.24.6. Immunodeficient Rats
14.25. Canada Rat Model Market Forecast, by Service
14.25.1. Breeding
14.25.2. Cryopreservation
14.25.3. Quarantine
14.25.4. Rederivation
14.25.5. Model-in-licensing
14.25.6. Genetic Testing
14.25.7. Other Services
14.26. Canada Rat Model Market Forecast, by Therapeutic Area
14.26.1. Toxicology
14.26.2. Oncology
14.26.3. Immunology and Inflammation
14.26.4. Neurology
14.26.5. Diabetes
14.26.6. Other Therapeutic Areas
14.27. Canada Rat Model Market Forecast, by Care Product
14.27.1. Cages
14.27.2. Feed
14.27.3. Bedding
14.27.4. Others
14.28. Canada Rat Model Market Forecast, by End-user
14.28.1. Pharmaceutical & Biotechnology Companies
14.28.2. Academic & Research Institutes
14.28.3. Contract Research Organizations (CROs)
14.29. Canada Rat Model Market Forecast, by Technology
14.29.1. CRISPR
14.29.2. Microinjection
14.29.3. Embryonic Stem Cell
14.29.4. Nuclear Transfer
14.30. North America Rat Model Market Attractiveness Analysis
14.30.1. By Model Type
14.30.2. By Service
14.30.3. By Therapeutic Area
14.30.4. By Care Product
14.30.5. By End-user
14.31. PEST Analysis
14.32. Key Trends
14.33. Key Developments
15. Europe Rat Model Market Analysis
15.1. Key Findings
15.2. Europe Rat Model Market Overview
15.3. Europe Rat Model Market Value Share Analysis, by Model Type
15.4. Europe Rat Model Market Forecast, by Model Type
15.4.1. Outbred Rats
15.4.2. Inbred Rats
15.4.3. Knockout/Genetically Modified Rats
15.4.4. Hybrid/Congenic Rats
15.4.5. Conditioned/Surgically Modified Rats
15.4.6. Immunodeficient Rats
15.5. Europe Rat Model Market Value Share Analysis, by Service
15.6. Europe Rat Model Market Forecast, by Service
15.6.1. Breeding
15.6.2. Cryopreservation
15.6.3. Quarantine
15.6.4. Rederivation
15.6.5. Model-in-licensing
15.6.6. Genetic Testing
15.6.7. Other Services
15.7. Europe Rat Model Market Value Share Analysis, by Therapeutic Area
15.8. Europe Rat Model Market Forecast, by Therapeutic Area
15.8.1. Toxicology
15.8.2. Oncology
15.8.3. Immunology and Inflammation
15.8.4. Neurology
15.8.5. Diabetes
15.8.6. Other Therapeutic Areas
15.8.7. Europe Rat Model Market Value Share Analysis, by Care Product
15.9. Europe Rat Model Market Forecast, by Care Product
15.9.1. Cages
15.9.2. Feed
15.9.3. Bedding
15.9.4. Others
15.10. Europe Rat Model Market Value Share Analysis, by End-user
15.11. Europe Rat Model Market Forecast, by End-user
15.11.1. Pharmaceutical & Biotechnology Companies
15.11.2. Academic & Research Institutes
15.11.3. Contract Research Organizations (CROs)
15.12. Europe Rat Model Market Value Share Analysis, by Technology
15.13. Europe Rat Model Market Forecast, by Technology
15.13.1. CRISPR
15.13.2. Microinjection
15.13.3. Embryonic Stem Cell
15.13.4. Nuclear Transfer
15.14. Europe Rat Model Market Value Share Analysis, by Country
15.15. Europe Rat Model Market Forecast, by Country
15.15.1. Germany
15.15.2. U.K.
15.15.3. France
15.15.4. Italy
15.15.5. Spain
15.15.6. Rest of Europe
15.16. Europe Rat Model Market Analysis, by Country
15.17. Germany Rat Model Market Forecast, by Model Type
15.17.1. Outbred Rats
15.17.2. Inbred Rats
15.17.3. Knockout/Genetically Modified Rats
15.17.4. Hybrid/Congenic Rats
15.17.5. Conditioned/Surgically Modified Rats
15.17.6. Immunodeficient Rats
15.18. Germany Rat Model Market Forecast, by Service
15.18.1. Breeding
15.18.2. Cryopreservation
15.18.3. Quarantine
15.18.4. Rederivation
15.18.5. Model-in-licensing
15.18.6. Genetic Testing
15.18.7. Other Services
15.19. Germany Rat Model Market Forecast, by Therapeutic Area
15.19.1. Toxicology
15.19.2. Oncology
15.19.3. Immunology and Inflammation
15.19.4. Neurology
15.19.5. Diabetes
15.19.6. Other Therapeutic Areas
15.20. Germany Rat Model Market Forecast, by Care Product
15.20.1. Cages
15.20.2. Feed
15.20.3. Bedding
15.20.4. Others
15.21. Germany Rat Model Market Forecast, by End-user
15.21.1. Pharmaceutical & Biotechnology Companies
15.21.2. Academic & Research Institutes
15.21.3. Contract Research Organizations (CROs)
15.22. Germany Rat Model Market Forecast, by Technology
15.22.1. CRISPR
15.22.2. Microinjection
15.22.3. Embryonic Stem Cell
15.22.4. Nuclear Transfer
15.23. U.K. Rat Model Market Forecast, by Model Type
15.23.1. Outbred Rats
15.23.2. Inbred Rats
15.23.3. Knockout/Genetically Modified Rats
15.23.4. Hybrid/Congenic Rats
15.23.5. Conditioned/Surgically Modified Rats
15.23.6. Immunodeficient Rats
15.24. U.K. Rat Model Market Forecast, by Service
15.24.1. Breeding
15.24.2. Cryopreservation
15.24.3. Quarantine
15.24.4. Rederivation
15.24.5. Model-in-licensing
15.24.6. Genetic Testing
15.24.7. Other Services
15.25. U.K. Rat Model Market Forecast, by Therapeutic Area
15.25.1. Toxicology
15.25.2. Oncology
15.25.3. Immunology and Inflammation
15.25.4. Neurology
15.25.5. Diabetes
15.25.6. Other Therapeutic Areas
15.26. U.K. Rat Model Market Forecast, by Care Product
15.26.1. Cages
15.26.2. Feed
15.26.3. Bedding
15.26.4. Others
15.27. U.K. Rat Model Market Forecast, by End-user
15.27.1. Pharmaceutical & Biotechnology Companies
15.27.2. Academic & Research Institutes
15.27.3. Contract Research Organizations (CROs)
15.28. U.K. Rat Model Market Forecast, by Technology
15.28.1. CRISPR
15.28.2. Microinjection
15.28.3. Embryonic Stem Cell
15.28.4. Nuclear Transfer
15.29. France Rat Model Market Forecast, by Model Type
15.29.1. Outbred Rats
15.29.2. Inbred Rats
15.29.3. Knockout/Genetically Modified Rats
15.29.4. Hybrid/Congenic Rats
15.29.5. Conditioned/Surgically Modified Rats
15.29.6. Immunodeficient Rats
15.30. France Rat Model Market Forecast, by Service
15.30.1. Breeding
15.30.2. Cryopreservation
15.30.3. Quarantine
15.30.4. Rederivation
15.30.5. Model-in-licensing
15.30.6. Genetic Testing
15.30.7. Other Services
15.31. France Rat Model Market Forecast, by Therapeutic Area
15.31.1. Toxicology
15.31.2. Oncology
15.31.3. Immunology and Inflammation
15.31.4. Neurology
15.31.5. Diabetes
15.31.6. Other Therapeutic Areas
15.32. France Rat Model Market Forecast, by Care Product
15.32.1. Cages
15.32.2. Feed
15.32.3. Bedding
15.32.4. Others
15.33. France Rat Model Market Forecast, by End-user
15.33.1. Pharmaceutical & Biotechnology Companies
15.33.2. Academic & Research Institutes
15.33.3. Contract Research Organizations (CROs)
15.34. France Rat Model Market Forecast, by Technology
15.34.1. CRISPR
15.34.2. Microinjection
15.34.3. Embryonic Stem Cell
15.34.4. Nuclear Transfer
15.35. Italy Rat Model Market Forecast, by Model Type
15.35.1. Outbred Rats
15.35.2. Inbred Rats
15.35.3. Knockout/Genetically Modified Rats
15.35.4. Hybrid/Congenic Rats
15.35.5. Conditioned/Surgically Modified Rats
15.35.6. Immunodeficient Rats
15.36. Italy Rat Model Market Forecast, by Service
15.36.1. Breeding
15.36.2. Cryopreservation
15.36.3. Quarantine
15.36.4. Rederivation
15.36.5. Model-in-licensing
15.36.6. Genetic Testing
15.36.7. Other Services
15.37. Italy Rat Model Market Forecast, by Therapeutic Area
15.37.1. Toxicology
15.37.2. Oncology
15.37.3. Immunology and Inflammation
15.37.4. Neurology
15.37.5. Diabetes
15.37.6. Other Therapeutic Areas
15.38. Italy Rat Model Market Forecast, by Care Product
15.38.1. Cages
15.38.2. Feed
15.38.3. Bedding
15.38.4. Others
15.39. Italy Rat Model Market Forecast, by End-user
15.39.1. Pharmaceutical & Biotechnology Companies
15.39.2. Academic & Research Institutes
15.39.3. Contract Research Organizations (CROs)
15.40. Italy Rat Model Market Forecast, by Technology
15.40.1. CRISPR
15.40.2. Microinjection
15.40.3. Embryonic Stem Cell
15.40.4. Nuclear Transfer
15.41. Spain Rat Model Market Forecast, by Model Type
15.41.1. Outbred Rats
15.41.2. Inbred Rats
15.41.3. Knockout/Genetically Modified Rats
15.41.4. Hybrid/Congenic Rats
15.41.5. Conditioned/Surgically Modified Rats
15.41.6. Immunodeficient Rats
15.42. Spain Rat Model Market Forecast, by Service
15.42.1. Breeding
15.42.2. Cryopreservation
15.42.3. Quarantine
15.42.4. Rederivation
15.42.5. Model-in-licensing
15.42.6. Genetic Testing
15.42.7. Other Services
15.43. Spain Rat Model Market Forecast, by Therapeutic Area
15.43.1. Toxicology
15.43.2. Oncology
15.43.3. Immunology and Inflammation
15.43.4. Neurology
15.43.5. Diabetes
15.43.6. Other Therapeutic Areas
15.44. Spain Rat Model Market Forecast, by Care Product
15.44.1. Cages
15.44.2. Feed
15.44.3. Bedding
15.44.4. Others
15.45. Spain Rat Model Market Forecast, by End-user
15.45.1. Pharmaceutical & Biotechnology Companies
15.45.2. Academic & Research Institutes
15.45.3. Contract Research Organizations (CROs)
15.46. Germany Rat Model Market Forecast, by Technology
15.46.1. CRISPR
15.46.2. Microinjection
15.46.3. Embryonic Stem Cell
15.46.4. Nuclear Transfer
15.47. Rest of Europe Rat Model Market Forecast, by Model Type
15.47.1. Outbred Rats
15.47.2. Inbred Rats
15.47.3. Knockout/Genetically Modified Rats
15.47.4. Hybrid/Congenic Rats
15.47.5. Conditioned/Surgically Modified Rats
15.47.6. Immunodeficient Rats
15.48. Rest of Europe Rat Model Market Forecast, by Service
15.48.1. Breeding
15.48.2. Cryopreservation
15.48.3. Quarantine
15.48.4. Rederivation
15.48.5. Model-in-licensing
15.48.6. Genetic Testing
15.48.7. Other Services
15.49. Rest of Europe Rat Model Market Forecast, by Therapeutic Area
15.49.1. Toxicology
15.49.2. Oncology
15.49.3. Immunology and Inflammation
15.49.4. Neurology
15.49.5. Diabetes
15.49.6. Other Therapeutic Areas
15.50. Rest Of Europe Rat Model Market Forecast, by Care Product
15.50.1. Cages
15.50.2. Feed
15.50.3. Bedding
15.50.4. Others
15.51. Rest Of Europe Rat Model Market Forecast, by End-user
15.51.1. Pharmaceutical & Biotechnology Companies
15.51.2. Academic & Research Institutes
15.51.3. Contract Research Organizations (CROs)
15.52. Rest Of Europe Rat Model Market Forecast, by Technology
15.52.1. CRISPR
15.52.2. Microinjection
15.52.3. Embryonic Stem Cell
15.52.4. Nuclear Transfer
15.53. Europe Rat Model Market Attractiveness Analysis
15.53.1. By Model Type
15.53.2. By Service
15.53.3. By Therapeutic Area
15.53.4. By Care Product
15.53.5. By End-user
15.54. PEST Analysis
15.55. Key Trends
15.56. Key Developments
16. Asia Pacific Rat Model Market Analysis
16.1. Key Findings
16.2. Asia Pacific Rat Model Market Overview
16.3. Asia Pacific Rat Model Market Value Share Analysis, by Model Type
16.4. Asia Pacific Rat Model Market Forecast, by Model Type
16.4.1. Outbred Rats
16.4.2. Inbred Rats
16.4.3. Knockout/Genetically Modified Rats
16.4.4. Hybrid/Congenic Rats
16.4.5. Conditioned/Surgically Modified Rats
16.4.6. Immunodeficient Rats
16.5. Asia Pacific Rat Model Market Value Share Analysis, by Service
16.6. Asia Pacific Rat Model Market Forecast, by Service
16.6.1. Breeding
16.6.2. Cryopreservation
16.6.3. Quarantine
16.6.4. Rederivation
16.6.5. Model-in-licensing
16.6.6. Genetic Testing
16.6.7. Other Services
16.7. Asia Pacific Rat Model Market Value Share Analysis, by Therapeutic Area
16.8. Asia Pacific Rat Model Market Forecast, by Therapeutic Area
16.8.1. Toxicology
16.8.2. Oncology
16.8.3. Immunology and Inflammation
16.8.4. Neurology
16.8.5. Diabetes
16.8.6. Other Therapeutic Areas
16.9. Asia Pacific Rat Model Market Value Share Analysis, by Care Product
16.10. Asia Pacific Rat Model Market Forecast, by Care Product
16.10.1. Cages
16.10.2. Feed
16.10.3. Bedding
16.10.4. Others
16.11. Asia Pacific Rat Model Market Value Share Analysis, by End-user
16.12. Asia Pacific Rat Model Market Forecast, by End-user
16.12.1. Pharmaceutical & Biotechnology Companies
16.12.2. Academic & Research Institutes
16.12.3. Contract Research Organizations (CROs)
16.13. Asia Pacific Rat Model Market Value Share Analysis, by Technology
16.14. Asia Pacific Rat Model Market Forecast, by Technology
16.14.1. CRISPR
16.14.2. Microinjection
16.14.3. Embryonic Stem Cell
16.14.4. Nuclear Transfer
16.15. Asia Pacific Rat Model Market Value Share Analysis, by Country
16.16. Asia Pacific Rat Model Market Forecast, by Country
16.16.1. China
16.16.2. India
16.16.3. Japan
16.16.4. ASEAN
16.16.5. Rest of Asia Pacific
16.17. Asia Pacific Rat Model Market Analysis, by Country
16.18. China Rat Model Market Forecast, by Model Type
16.18.1. Outbred Rats
16.18.2. Inbred Rats
16.18.3. Knockout/Genetically Modified Rats
16.18.4. Hybrid/Congenic Rats
16.18.5. Conditioned/Surgically Modified Rats
16.18.6. Immunodeficient Rats
16.19. China Rat Model Market Forecast, by Service
16.19.1. Breeding
16.19.2. Cryopreservation
16.19.3. Quarantine
16.19.4. Rederivation
16.19.5. Model-in-licensing
16.19.6. Genetic Testing
16.19.7. Other Services
16.20. China Rat Model Market Forecast, by Therapeutic Area
16.20.1. Toxicology
16.20.2. Oncology
16.20.3. Immunology and Inflammation
16.20.4. Neurology
16.20.5. Diabetes
16.20.6. Other Therapeutic Areas
16.21. China Rat Model Market Forecast, by Care Product
16.21.1. Cages
16.21.2. Feed
16.21.3. Bedding
16.21.4. Others
16.22. China Rat Model Market Forecast, by End-user
16.22.1. Pharmaceutical & Biotechnology Companies
16.22.2. Academic & Research Institutes
16.22.3. Contract Research Organizations (CROs)
16.23. China Rat Model Market Forecast, by Technology
16.23.1. CRISPR
16.23.2. Microinjection
16.23.3. Embryonic Stem Cell
16.23.4. Nuclear Transfer
16.24. India Rat Model Market Forecast, by Model Type
16.24.1. Outbred Rats
16.24.2. Inbred Rats
16.24.3. Knockout/Genetically Modified Rats
16.24.4. Hybrid/Congenic Rats
16.24.5. Conditioned/Surgically Modified Rats
16.24.6. Immunodeficient Rats
16.25. India Rat Model Market Forecast, by Service
16.25.1. Breeding
16.25.2. Cryopreservation
16.25.3. Quarantine
16.25.4. Rederivation
16.25.5. Model-in-licensing
16.25.6. Genetic Testing
16.25.7. Other Services
16.26. India Rat Model Market Forecast, by Therapeutic Area
16.26.1. Toxicology
16.26.2. Oncology
16.26.3. Immunology and Inflammation
16.26.4. Neurology
16.26.5. Diabetes
16.26.6. Other Therapeutic Areas
16.27. India Rat Model Market Forecast, by Care Product
16.27.1. Cages
16.27.2. Feed
16.27.3. Bedding
16.27.4. Others
16.28. India Rat Model Market Forecast, by End-user
16.28.1. Pharmaceutical & Biotechnology Companies
16.28.2. Academic & Research Institutes
16.28.3. Contract Research Organizations (CROs)
16.29. India Rat Model Market Forecast, by Technology
16.29.1. CRISPR
16.29.2. Microinjection
16.29.3. Embryonic Stem Cell
16.29.4. Nuclear Transfer
16.30. Japan Rat Model Market Forecast, by Model Type
16.30.1. Outbred Rats
16.30.2. Inbred Rats
16.30.3. Knockout/Genetically Modified Rats
16.30.4. Hybrid/Congenic Rats
16.30.5. Conditioned/Surgically Modified Rats
16.30.6. Immunodeficient Rats
16.31. Japan Rat Model Market Forecast, by Service
16.31.1. Breeding
16.31.2. Cryopreservation
16.31.3. Quarantine
16.31.4. Rederivation
16.31.5. Model-in-licensing
16.31.6. Genetic Testing
16.31.7. Other Services
16.32. Japan Rat Model Market Forecast, by Therapeutic Area
16.32.1. Toxicology
16.32.2. Oncology
16.32.3. Immunology and Inflammation
16.32.4. Neurology
16.32.5. Diabetes
16.32.6. Other Therapeutic Areas
16.33. Japan Rat Model Market Forecast, by Care Product
16.33.1. Cages
16.33.2. Feed
16.33.3. Bedding
16.33.4. Others
16.34. Japan Rat Model Market Forecast, by End-user
16.34.1. Pharmaceutical & Biotechnology Companies
16.34.2. Academic & Research Institutes
16.34.3. Contract Research Organizations (CROs)
16.35. Japan Rat Model Market Forecast, by Technology
16.35.1. CRISPR
16.35.2. Microinjection
16.35.3. Embryonic Stem Cell
16.35.4. Nuclear Transfer
16.36. ASEAN Rat Model Market Forecast, by Model Type
16.36.1. Outbred Rats
16.36.2. Inbred Rats
16.36.3. Knockout/Genetically Modified Rats
16.36.4. Hybrid/Congenic Rats
16.36.5. Conditioned/Surgically Modified Rats
16.36.6. Immunodeficient Rats
16.37. ASEAN Rat Model Market Forecast, by Service
16.37.1. Breeding
16.37.2. Cryopreservation
16.37.3. Quarantine
16.37.4. Rederivation
16.37.5. Model-in-licensing
16.37.6. Genetic Testing
16.37.7. Other Services
16.38. ASEAN Rat Model Market Forecast, by Therapeutic Area
16.38.1. Toxicology
16.38.2. Oncology
16.38.3. Immunology and Inflammation
16.38.4. Neurology
16.38.5. Diabetes
16.38.6. Other Therapeutic Areas
16.39. ASEAN Rat Model Market Forecast, by Care Product
16.39.1. Cages
16.39.2. Feed
16.39.3. Bedding
16.39.4. Others
16.40. ASEAN Rat Model Market Forecast, by End-user
16.40.1. Pharmaceutical & Biotechnology Companies
16.40.2. Academic & Research Institutes
16.40.3. Contract Research Organizations (CROs)
16.41. ASEAN Rat Model Market Forecast, by Technology
16.41.1. CRISPR
16.41.2. Microinjection
16.41.3. Embryonic Stem Cell
16.41.4. Nuclear Transfer
16.42. Rest of Asia Pacific Rat Model Market Forecast, by Model Type
16.42.1. Outbred Rats
16.42.2. Inbred Rats
16.42.3. Knockout/Genetically Modified Rats
16.42.4. Hybrid/Congenic Rats
16.42.5. Conditioned/Surgically Modified Rats
16.42.6. Immunodeficient Rats
16.43. Rest of Asia Pacific Rat Model Market Forecast, by Service
16.43.1. Breeding
16.43.2. Cryopreservation
16.43.3. Quarantine
16.43.4. Rederivation
16.43.5. Model-in-licensing
16.43.6. Genetic Testing
16.43.7. Other Services
16.44. Rest of Asia Pacific Rat Model Market Forecast, by Therapeutic Area
16.44.1. Toxicology
16.44.2. Oncology
16.44.3. Immunology and Inflammation
16.44.4. Neurology
16.44.5. Diabetes
16.44.6. Other Therapeutic Areas
16.45. Rest of Asia Pacific Rat Model Market Forecast, by Care Product
16.45.1. Cages
16.45.2. Feed
16.45.3. Bedding
16.45.4. Others
16.46. Rest of Asia Pacific Rat Model Market Forecast, by End-user
16.46.1. Pharmaceutical & Biotechnology Companies
16.46.2. Academic & Research Institutes
16.46.3. Contract Research Organizations (CROs)
16.47. Rest of Asia Pacific Rat Model Market Forecast, by technology
16.47.1. CRISPR
16.47.2. Microinjection
16.47.3. Embryonic Stem Cell
16.47.4. Nuclear Transfer
16.48. Asia Pacific Rat Model Market Attractiveness Analysis
16.48.1. By Model Type
16.48.2. By Service
16.48.3. By Therapeutic Area
16.48.4. By Care Product
16.48.5. By End-user
16.49. PEST Analysis
16.50. Key Trends
16.51. Key Developments
17. Middle East & Africa Rat Model Market Analysis
17.1. Key Findings
17.2. Middle East & Africa Rat Model Market Overview
17.3. Middle East & Africa Rat Model Market Value Share Analysis, by Model Type
17.4. Middle East & Africa Rat Model Market Forecast, by Model Type
17.4.1. Outbred Rats
17.4.2. Inbred Rats
17.4.3. Knockout/Genetically Modified Rats
17.4.4. Hybrid/Congenic Rats
17.4.5. Conditioned/Surgically Modified Rats
17.4.6. Immunodeficient Rats
17.5. Middle East & Africa Rat Model Market Value Share Analysis, by Service
17.6. Middle East & Africa Rat Model Market Forecast, by Service
17.6.1. Breeding
17.6.2. Cryopreservation
17.6.3. Quarantine
17.6.4. Rederivation
17.6.5. Model-in-licensing
17.6.6. Genetic Testing
17.6.7. Other Services
17.7. Middle East & Africa Rat Model Market Value Share Analysis, by Therapeutic Area
17.8. Middle East & Africa Rat Model Market Forecast, by Therapeutic Area
17.8.1. Toxicology
17.8.2. Oncology
17.8.3. Immunology and Inflammation
17.8.4. Neurology
17.8.5. Diabetes
17.8.6. Other Therapeutic Areas
17.9. Middle East & Africa Rat Model Market Value Share Analysis, by Care Product
17.10. Middle East & Africa Rat Model Market Forecast, by Care Product
17.10.1. Cages
17.10.2. Feed
17.10.3. Bedding
17.10.4. Others
17.11. Middle East & Africa Rat Model Market Value Share Analysis, by End-user
17.12. Middle East & Africa Rat Model Market Forecast, by End-user
17.12.1. Pharmaceutical & Biotechnology Companies
17.12.2. Academic & Research Institutes
17.12.3. Contract Research Organizations (CROs)
17.13. Middle East& Africa Rat Model Market Value Share Analysis, by Technology
17.14. Middle East & Africa Rat Model Market Forecast, by Technology
17.14.1. CRISPR
17.14.2. Microinjection
17.14.3. Embryonic Stem Cell
17.14.4. Nuclear Transfer
17.15. Middle East & Africa Rat Model Market Value Share Analysis, by Country
17.16. Middle East & Africa Rat Model Market Forecast, by Country
17.16.1. GCC
17.16.2. South Africa
17.16.3. Rest of Middle East & Africa
17.17. Middle East & Africa Rat Model Market Analysis, by Country
17.18. GCC Rat Model Market Forecast, by Model Type
17.18.1. Outbred Rats
17.18.2. Inbred Rats
17.18.3. Knockout/Genetically Modified Rats
17.18.4. Hybrid/Congenic Rats
17.18.5. Conditioned/Surgically Modified Rats
17.18.6. Immunodeficient Rats
17.19. GCC Rat Model Market Forecast, by Service
17.19.1. Breeding
17.19.2. Cryopreservation
17.19.3. Quarantine
17.19.4. Rederivation
17.19.5. Model-in-licensing
17.19.6. Genetic Testing
17.19.7. Other Services
17.20. GCC Rat Model Market Forecast, by Therapeutic Area
17.20.1. Toxicology
17.20.2. Oncology
17.20.3. Immunology and Inflammation
17.20.4. Neurology
17.20.5. Diabetes
17.20.6. Other Therapeutic Areas
17.21. GCC Rat Model Market Forecast, by Care Product
17.21.1. Cages
17.21.2. Feed
17.21.3. Bedding
17.21.4. Others
17.22. GCC Rat Model Market Forecast, by End-user
17.22.1. Pharmaceutical & Biotechnology Companies
17.22.2. Academic & Research Institutes
17.22.3. Contract Research Organizations (CROs)
17.23. GCC Rat Model Market Forecast, by Technology
17.23.1. CRISPR
17.23.2. Microinjection
17.23.3. Embryonic Stem Cell
17.23.4. Nuclear Transfer
17.24. South Africa Rat Model Market Forecast, by Model Type
17.24.1. Outbred Rats
17.24.2. Inbred Rats
17.24.3. Knockout/Genetically Modified Rats
17.24.4. Hybrid/Congenic Rats
17.24.5. Conditioned/Surgically Modified Rats
17.24.6. Immunodeficient Rats
17.25. South Africa Rat Model Market Forecast, by Service
17.25.1. Breeding
17.25.2. Cryopreservation
17.25.3. Quarantine
17.25.4. Rederivation
17.25.5. Model-in-licensing
17.25.6. Genetic Testing
17.25.7. Other Services
17.26. South Africa Rat Model Market Forecast, by Therapeutic Area
17.26.1. Toxicology
17.26.2. Oncology
17.26.3. Immunology and Inflammation
17.26.4. Neurology
17.26.5. Diabetes
17.26.6. Other Therapeutic Areas
17.27. South Africa Rat Model Market Forecast, by Care Product
17.27.1. Cages
17.27.2. Feed
17.27.3. Bedding
17.27.4. Others
17.28. South Africa Rat Model Market Forecast, by End-user
17.28.1. Pharmaceutical & Biotechnology Companies
17.28.2. Academic & Research Institutes
17.28.3. Contract Research Organizations (CROs)
17.29. South Africa Rat Model Market Forecast, by Technolgy
17.29.1. CRISPR
17.29.2. Microinjection
17.29.3. Embryonic Stem Cell
17.29.4. Nuclear Transfer
17.30. Rest of Middle East & Africa Rat Model Market Forecast, by Model Type
17.30.1. Outbred Rats
17.30.2. Inbred Rats
17.30.3. Knockout/Genetically Modified Rats
17.30.4. Hybrid/Congenic Rats
17.30.5. Conditioned/Surgically Modified Rats
17.30.6. Immunodeficient Rats
17.31. Rest of Middle East & Africa Rat Model Market Forecast, by Service
17.31.1. Breeding
17.31.2. Cryopreservation
17.31.3. Quarantine
17.31.4. Rederivation
17.31.5. Model-in-licensing
17.31.6. Genetic Testing
17.31.7. Other Services
17.32. Rest of Middle East & Africa Rat Model Market Forecast, by Therapeutic Area
17.32.1. Toxicology
17.32.2. Oncology
17.32.3. Immunology and Inflammation
17.32.4. Neurology
17.32.5. Diabetes
17.32.6. Other Therapeutic Areas
17.33. Rest of Middle East & Africa Rat Model Market Forecast, by Care Product
17.33.1. Cages
17.33.2. Feed
17.33.3. Bedding
17.33.4. Others
17.34. Rest of Middle East & Africa Rat Model Market Forecast, by End-user
17.34.1. Pharmaceutical & Biotechnology Companies
17.34.2. Academic & Research Institutes
17.34.3. Contract Research Organizations (CROs)
17.35. Rest of Middle East & Africa Rat Model Market Forecast, by Technology
17.35.1. CRISPR
17.35.2. Microinjection
17.35.3. Embryonic Stem Cell
17.35.4. Nuclear Transfer
17.36. Middle East & Africa Rat Model Market Attractiveness Analysis
17.36.1. By Model Type
17.36.2. By Service
17.36.3. By Therapeutic Area
17.36.4. By Care Product
17.36.5. By End-user
17.37. PEST Analysis
17.38. Key Trends
17.39. Key Developments
18. South America Rat Model Market Analysis
18.1. Key Findings
18.2. South America Rat Model Market Overview
18.3. South America Rat Model Market Value Share Analysis, by Model Type
18.4. South America Rat Model Market Forecast, by Model Type
18.4.1. Outbred Rats
18.4.2. Inbred Rats
18.4.3. Knockout/Genetically Modified Rats
18.4.4. Hybrid/Congenic Rats
18.4.5. Conditioned/Surgically Modified Rats
18.4.6. Immunodeficient Rats
18.5. South America Rat Model Market Value Share Analysis, by Service
18.6. South America Rat Model Market Forecast, by Service
18.6.1. Breeding
18.6.2. Cryopreservation
18.6.3. Quarantine
18.6.4. Rederivation
18.6.5. Model-in-licensing
18.6.6. Genetic Testing
18.6.7. Other Services
18.7. South America Rat Model Market Value Share Analysis, by Therapeutic Area
18.8. South America Rat Model Market Forecast, by Therapeutic Area
18.8.1. Toxicology
18.8.2. Oncology
18.8.3. Immunology and Inflammation
18.8.4. Neurology
18.8.5. Diabetes
18.8.6. Other Therapeutic Areas
18.9. South America Rat Model Market Value Share Analysis, by Care Product
18.10. South America Rat Model Market Forecast, by Care Product
18.10.1. Cages
18.10.2. Feed
18.10.3. Bedding
18.10.4. Others
18.11. South America Rat Model Market Value Share Analysis, by End-user
18.12. South America Rat Model Market Forecast, by End-user
18.12.1. Pharmaceutical & Biotechnology Companies
18.12.2. Academic & Research Institutes
18.12.3. Contract Research Organizations (CROs)
18.13. South America Rat Model Market Value Share Analysis, by Technology
18.14. South America Rat Model Market Forecast, by Technology
18.14.1. CRISPR
18.14.2. Microinjection
18.14.3. Embryonic Stem Cell
18.14.4. Nuclear Transfer
18.15. South America Rat Model Market Value Share Analysis, by Country
18.16. South America Rat Model Market Forecast, by Country
18.16.1. Brazil
18.16.2. Mexico
18.16.3. Rest of South America
18.17. South America Rat Model Market Analysis, by Country
18.18. Brazil Rat Model Market Forecast, by Model Type
18.18.1. Outbred Rats
18.18.2. Inbred Rats
18.18.3. Knockout/Genetically Modified Rats
18.18.4. Hybrid/Congenic Rats
18.18.5. Conditioned/Surgically Modified Rats
18.18.6. Immunodeficient Rats
18.19. Brazil Rat Model Market Forecast, by Service
18.19.1. Breeding
18.19.2. Cryopreservation
18.19.3. Quarantine
18.19.4. Rederivation
18.19.5. Model-in-licensing
18.19.6. Genetic Testing
18.19.7. Other Services
18.20. Brazil Rat Model Market Forecast, by Therapeutic Area
18.20.1. Toxicology
18.20.2. Oncology
18.20.3. Immunology and Inflammation
18.20.4. Neurology
18.20.5. Diabetes
18.20.6. Other Therapeutic Areas
18.21. Brazil Rat Model Market Forecast, by Care Product
18.21.1. Cages
18.21.2. Feed
18.21.3. Bedding
18.21.4. Others
18.22. Brazil Rat Model Market Forecast, by End-user
18.22.1. Pharmaceutical & Biotechnology Companies
18.22.2. Academic & Research Institutes
18.22.3. Contract Research Organizations (CROs)
18.23. Brazil Rat Model Market Forecast, by Technology
18.23.1. CRISPR
18.23.2. Microinjection
18.23.3. Embryonic Stem Cell
18.23.4. Nuclear Transfer
18.24. Mexico Rat Model Market Forecast, by Model Type
18.24.1. Outbred Rats
18.24.2. Inbred Rats
18.24.3. Knockout/Genetically Modified Rats
18.24.4. Hybrid/Congenic Rats
18.24.5. Conditioned/Surgically Modified Rats
18.24.6. Immunodeficient Rats
18.25. Mexico Rat Model Market Forecast, by Service
18.25.1. Breeding
18.25.2. Cryopreservation
18.25.3. Quarantine
18.25.4. Rederivation
18.25.5. Model-in-licensing
18.25.6. Genetic Testing
18.25.7. Other Services
18.26. Mexico Rat Model Market Forecast, by Therapeutic Area
18.26.1. Toxicology
18.26.2. Oncology
18.26.3. Immunology and Inflammation
18.26.4. Neurology
18.26.5. Diabetes
18.26.6. Other Therapeutic Areas
18.27. Mexico Rat Model Market Forecast, by Care Product
18.27.1. Cages
18.27.2. Feed
18.27.3. Bedding
18.27.4. Others
18.28. Mexico Rat Model Market Forecast, by End-user
18.28.1. Pharmaceutical & Biotechnology Companies
18.28.2. Academic & Research Institutes
18.28.3. Contract Research Organizations (CROs)
18.29. Mexico Rat Model Market Forecast, by Technology
18.29.1. CRISPR
18.29.2. Microinjection
18.29.3. Embryonic Stem Cell
18.29.4. Nuclear Transfer
18.30. Mexico Rat Model Market Forecast, by End-user
18.30.1. CRISPR
18.30.2. Microinjection
18.30.3. Embryonic Stem Cell
18.30.4. Nuclear Transfer
18.31. Rest of South America Rat Model Market Forecast, by Model Type
18.31.1. Outbred Rats
18.31.2. Inbred Rats
18.31.3. Knockout/Genetically Modified Rats
18.31.4. Hybrid/Congenic Rats
18.31.5. Conditioned/Surgically Modified Rats
18.31.6. Immunodeficient Rats
18.32. Rest of South America Rat Model Market Forecast, by Service
18.32.1. Breeding
18.32.2. Cryopreservation
18.32.3. Quarantine
18.32.4. Rederivation
18.32.5. Model-in-licensing
18.32.6. Genetic Testing
18.32.7. Other Services
18.33. Rest of South America Rat Model Market Forecast, by Therapeutic Area
18.33.1. Toxicology
18.33.2. Oncology
18.33.3. Immunology and Inflammation
18.33.4. Neurology
18.33.5. Diabetes
18.33.6. Other Therapeutic Areas
18.34. Rest of South America Rat Model Market Forecast, by Care Product
18.34.1. Cages
18.34.2. Feed
18.34.3. Bedding
18.34.4. Others
18.35. Rest of South America Rat Model Market Forecast, by End-user
18.35.1. Pharmaceutical & Biotechnology Companies
18.35.2. Academic & Research Institutes
18.35.3. Contract Research Organizations (CROs)
18.36. Rest of South America Rat Model Market Forecast, by Technology
18.36.1. CRISPR
18.36.2. Microinjection
18.36.3. Embryonic Stem Cell
18.36.4. Nuclear Transfer
18.37. South America Rat Model Market Attractiveness Analysis
18.37.1. By Model Type
18.37.2. By Service
18.37.3. By Therapeutic Area
18.37.4. By Care Product
18.37.5. By End-user
18.38. PEST Analysis
18.39. Key Trends
18.40. Key Developments
19. Company Profiles
19.1. Market Share Analysis, by Company
19.2. Competition Matrix
19.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
19.2.2. New Product Launches and Product Enhancements
19.2.3. Market Consolidation
19.2.3.1. M&A by Regions, Investment and Applications
19.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
19.3. Company Profiles: Key Players
19.3.1. Genoway S.A
19.3.1.1. Company Overview
19.3.1.2. Financial Overview
19.3.1.3. Product Portfolio
19.3.1.4. Business Strategy
19.3.1.5. Recent Developments
19.3.1.6. Developing Footprint
19.3.2. Biomere
19.3.3. Transposagen Biopharmaceuticals, Inc.
19.3.4. Horizon Discovery Group PLC
19.3.5. Transviragen, Inc.
19.3.6. Charles River Laboratories International, Inc.
19.3.7. Taconic Biosciences, Inc.
19.3.8. Envigo
19.3.9. Laboratory Corporation of America Holdings
19.3.10. Janvier Labs
19.3.11. Harlan Laboratories, Inc.
19.3.12. SAGE Labs
19.3.13. Applied StemCell
19.3.14. Regenera Pharma
19.3.15. Active C60
20. Primary Key Insights